BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

EUCODIS Bioscience Signs Research Agreement With Genencor International, Inc.


5/21/2009 11:13:56 AM

VIENNA, Austria, May 21 /PRNewswire/ -- EUCODIS Bioscience, a company developing, manufacturing, and marketing enzymes and other proteins for the chemical industry, announced today that it has entered into a research agreement with Genencor, a division of Danisco. Under the terms of the agreement, EUCODIS Bioscience will apply its proprietary, patent-protected technology of "in vivo recombination" to the development of an optimized version of an undisclosed enzyme. The Company will generate a library of recombinants of the enzyme, and Genencor will screen the library for clones (enzymes) with desired product profiles.

"We are pleased that Genencor, a leading enzyme manufacturer and one of the largest biotechnology companies worldwide, has chosen EUCODIS Bioscience as a partner", said Rudy Pandjaitan, PhD, CEO of EUCODIS Bioscience. "In previous development programs - both for our own portfolio of commercial enzymes and for industrial partners - our technology of in vivo recombination has reliably shown its capacity to generate high-quality libraries of active enzymes with significant improvement of the desired activities in a single cycle of recombination."

About EUCODIS Bioscience

EUCODIS Bioscience GmbH develops, manufactures, and markets industrial enzymes.

EUCODIS Bioscience' products help customers in the chemical, pharmaceutical, and food and feed industries to make manufacturing processes more efficient and cleaner, and to generate products with superior properties.

EUCODIS Bioscience originally focused on developing enzymes for industrial partners, including GlaxoSmithKline, Henkel, and Lohmann Animal Health. Since 2009, the Company also markets its own products.

Led by an experienced management team, EUCODIS Bioscience is backed by Austrian and German institutional venture capital funds, founders, and private investors. The Company is headquartered in Austria, Europe, with subsidiaries in France and Germany.

CONTACT: Company contact EUCODIS Bioscience: Rudy Pandjaitan, PhD, CEO,
EUCODIS Bioscience, Brunner Strasse 59, 1230 VIENNA, AUSTRIA,
+43-1-86634-9241, office@eucodisbioscience.com; Media contact EUCODIS
Bioscience: Frank Butschbacher, Investor Relations & Communications,
http://www.butschbacher.net, +43-650-7844940, office@butschbacher.net



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES